Biotechnology Management Operations 
N2Growth Blog
DECEMBER 5, 2024
We leverage our global network to access high-caliber professionals across research and development, clinical operations, regulatory affairs, and commercialization disciplines. Rapid advancements in biotechnology and personalized medicine have increased the demand for specialized expertise, outpacing the supply.
Tanveer Naseer
OCTOBER 20, 2015
The first leader was someone I worked with as part of the management team at a biotechnology firm, and how he guided our organization during the merger of our North American parent company with a much larger European multinational.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Strategy Driven
MAY 12, 2021
Unlike 3D films made for the cinema or stereoscopic televisions operating with glasses, such 3D displays require proprietary content combining as many as eight discrete images. There are already a dozen volumetric capture studios operating around the world that work by pointing dozens, even hundreds of cameras at a group on vast stages.
Harvard Business Review
MAY 2, 2011
Without operating in the former, they won't be able to attain economies of scale; sans the latter, they're unlikely to continue developing state-of-the-art technologies. Another CEO of a fast-growing biotechnology venture, a Chinese-American entrepreneur, added that he wanted his company to be perceived as American rather than as Chinese.
Harvard Business Review
MARCH 2, 2012
As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. economy, expands America's global trade, and attracts foreign companies to base operations in the U.S.
Harvard Business Review
MAY 1, 2014
I learned this while leading a turnaround of NPS Pharmaceuticals , a biotechnology company that now specializes in creating treatments for rare diseases. To save the 20-year-old company, I had to get it operating like a start-up. Change management Managing people Organizational culture' Your values must be non-negotiable.
Harvard Business Review
FEBRUARY 17, 2011
The reason for the interest in in part because the industry has suffered from poor returns on investment over the last decade; indeed, some sectors, including biotechnology, report negative aggregate returns. China and India, in particular, offer attractive liquidity and investment opportunities VCs haven't seen for a while.
Expert insights. Personalized for you.
195 
Let's personalize your content